logo

Qlt Inc/Bc (NVLN)



Trade NVLN now with
  Date
  Headline
8/30/2019 8:07:16 AM Novelion Therapeutics Updates On Delisting From Nasdaq
7/5/2019 8:34:40 AM Novelion Therapeutics Receives Delisting Notifications
6/24/2019 8:35:50 AM Novelion Therapeutics Believes That Whitefort Action Lacks Any Merit
5/20/2019 11:00:20 PM Novelion's Aegerion To Recapitalize Through Court Supervised Process; Amryt To Buy 100% Of Reorganized Stock Of Aegerion
2/6/2019 2:33:35 AM Novelion Subsidiary Enters Licensing Agreement For JUXTAPID In Japan
11/9/2018 8:48:32 AM Novelion Therapeutics Q3 GAAP Net Loss $24.8 Mln Vs Net Loss $49.7 Mln Last Year
11/8/2018 8:50:29 AM Novelion Subsidiary Enters Term Loan Agreement
8/7/2018 8:35:20 AM Novelion Therapeutics Q2 GAAP Net Loss $31.3 Mln Vs Loss Of $21.4 Mln Last Year
7/3/2018 8:32:20 AM Novelion Therapeutics Appoints Mark Corrigan As Executive Chair Of The Board
6/25/2018 8:14:11 AM Novelion Therapeutics Reports Presentation Of Positive Metreleptin Data At ADA Scientific Sessions
6/1/2018 7:56:10 AM Novelion Therapeutics: MYALEPTA Gets Positive CHMP Opinion In Patients With Generalized And Partial Lipodystrophy
5/10/2018 8:35:12 AM Novelion Therapeutics Q1 Net Loss $32.8 Mln Or $1.76/Shr Vs Loss $30.96 Mln Or $1.67/Shr Last Year
1/30/2018 6:03:42 PM Novelion Says A U.S. District Court Judge Has Sentenced Its Subsidiary Aegerion
  
 
>